Artivion Inc Investor & Analyst Day Transcript
Good morning, everybody. Thank you for joining us here in New York at the Pierre. I'm Pat Mackin, I'm the CEO of Artivion, and welcome to our Analyst Day. A quick look at our forward-looking statements. Let me walk you through the agenda. So this morning, we've got a really, I think, a full pack schedule for you. I'm going to do a brief overview of the company. I'm going to be followed by John Davis, our Senior Vice President of Sales and Marketing, to talk about the On-X franchise. He'll be followed by John Alexander, who will -- from Duke University who'll talk about the PROACT Xa trial. We're then going to do our first Q&A and that's going to be covering whatever topics we've already been through.
We're then going to go into our stent grafts. Our Head of Europe, Karl Will, who is here from Germany, will present our stent graft franchise. And then it will be followed by 3 speakers. Dr. Kempfert on AMDS; Dr. Shrestha on Neo; and Dr. Tim Resch, who's here with us from Copenhagen on E-nside. Dr. Kempfert and Shrestha will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
